Almirall SA banner

Intrinsic Value

The intrinsic value of Almirall SA (E2Z) under the Base Case is 12.74 EUR per share. Compared with the current market price of 9.93 EUR, the stock appears Undervalued by 22% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

E2Z Intrinsic Value
€12.74
Undervaluation 22%
Intrinsic Value
Price €9.93

E2Z is cheaper than usual. It was this cheap or cheaper on just 3% of days in the past 5 years.

Monitor E2Z
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €10.19
Get notified when the price drops into your buy zone
Intrinsic Value €12.74
Margin of Safety 20% €10.19
Current Price €9.93
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to E2Z

Fundamental Analysis

What Almirall Does

Pharmaceuticals Health Care

Almirall SA is a Spanish pharmaceutical company focused mainly on skin disease medicines. It develops and sells prescription drugs for conditions such as psoriasis, acne, eczema, and other dermatology problems. The company also works on treatments in allergy and other specialty care areas, but dermatology is its core business.

Headquarters
Spain ES
Employees
2 108
IPO date
Apr 19, 2007
Read the full company overview
View Company Overview

Latest Earnings Call

Q2 2026 · July 24, 2026

Open the earnings call
EPS
€0.11
Expected
€0.13
Surprise
−14.2%
Stock, next trading day
+1.6%
View Earnings Call
Financials
Efficiency

Earnings Waterfall
Almirall SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one E2Z stock?

The intrinsic value for Almirall SA (E2Z) under the Base Case is 12.74 EUR.

Is E2Z stock undervalued or overvalued?

Compared with the current market price of 9.93 EUR, the stock appears Undervalued by 22% .

Back to Top